Randomized trials of adjuvant tamoxifen versus tamoxifen and octreotide LAR in early-stage breast cancer: NCIC CTG MA.14 and NSABP B-29.
Judy-Anne W. Chapman
No relevant relationships to disclose
Joseph P. Costantino
No relevant relationships to disclose
Bin Dong
No relevant relationships to disclose
Richard G. Margolese
No relevant relationships to disclose
Kathleen I. Pritchard
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Karen A. Gelmon
No relevant relationships to disclose
Norman Wolmark
No relevant relationships to disclose
Michael N. Pollak
Research Funding - Novartis